Title Collection Author Date
Healthcare Stocks for a Healthy Retirement Investor Views Emma Simon 19/02/20
Reckitt Shares Rise After Suboxone Settlement Equity Research & Insights James Gard 11/07/19
Top Asian Healthcare Stocks Perspectives External Writer 09/04/19
How to Tap Into the Genetics Revolution Perspectives EdenTree 29/03/19
Can Healthcare Stocks Continue their 2018 Rally? Equity Research & Insights David Brenchley 30/01/19
GSK Pfizer Joint Venture No Impact on Company Value Equity Research & Insights Damien Conover, CFA 20/12/18
Healthcare Stocks Aren't Cheap But Offer Attractive Returns Equity Research & Insights Philip Straehl 22/11/18
Henderson Backs Two Tech Alternative Trusts Investment Trust Research & Insights David Brenchley 25/09/18
Healthcare: Profit from an Ageing Population Market Update Emma Wall 17/09/18
ETF Investors Look to Healthcare Stocks ETF Research & Insights David Brenchley 13/09/18
GlaxoSmithKline Shares Still Undervalued Equity Research & Insights Damien Conover 31/07/18
Shire Stock Undervalued Despite Takeover Bid Equity Research & Insights Karen Andersen, CFA 20/04/18
Can FTSE 100 Drug Giants Weather US Reforms? Equity Research & Insights Damien Conover 29/03/18
Takeda Takeover Bid for Shire: Analyst View Equity Research & Insights Karen Andersen, CFA 29/03/18
Novartis Deal Will Strengthen Glaxo's Dividend say Analysts Equity Research & Insights Damien Conover, CFA 28/03/18
Glaxo Dividend Cut Unlikely say Analysts Equity Research & Insights Damien Conover 26/10/17
Revealed: The Funds Hit by AstraZeneca Slump Fund Research & Insights Karen Kwok 27/07/17
AstraZeneca Falls 16% as Drug Trial Falters Equity Research & Insights Emma Wall 27/07/17
Pfizer Offers Dividend Opportunity Equity Research & Insights Damien Conover, CFA 07/06/17
Biotech Trusts Trade at Discount Investment Trust Research & Insights Karen Kwok 26/05/17
Are Healthcare Stocks Too Expensive? Equity Research & Insights Dan Kemp 02/05/17
Will Trump’s Policies Provide a Boost or Brake on Healthcare Funds? Fund Research & Insights Sam Shaw 07/02/17
UK Pharma Stocks Fall as Trump Repeals Obamacare Equity Research & Insights Karen Kwok 02/02/17
Pharma Stocks Remain Undervalued Despite Clinton Loss Equity Research & Insights Karen Kwok 29/11/16
What Does President Trump Mean for Healthcare Stocks? Equity Research & Insights Damien Conover, CFA 10/11/16
Healthcare and Mining Stocks Gain On Trump Win Equity Research & Insights Karen Kwok 09/11/16
AstraZeneca Shares Upgraded Thanks to Weak Sterling Equity Research & Insights Damien Conover, CFA 24/10/16
Why Healthcare Stocks Will be the Real Winner of the US Election Equity Research & Insights Karen Kwok 26/09/16
How the US Election is Creating Investment Opportunities Equity Research & Insights Daniel Vaughan, CFA 26/04/16
JPMorgan: We're Shorting Emerging Markets Equity Research & Insights Emma Wall 22/04/16
US Election is the Biggest Challenge to Healthcare Stocks Equity Research & Insights Karen Kwok 14/04/16
Analysts Downgrade Shire Equity Research & Insights Stefan Quenneville, CFA 15/02/16
AstraZeneca Credit Rating Downgraded by Analysts Bond Investing Morningstar Credit Committee 03/12/15
AstraZeneca Fairly Valued after Solid Q3 Equity Research & Insights Damien Conover, CFA 10/11/15
Smith & Nephew Ripe for Takeover Bid say Analysts Equity Research & Insights Debbie S. Wang 20/10/15
Pharmaceutical Stocks Get Sales Boost from Clinical Report Equity Research & Insights Damien Conover, CFA 15/05/15
Investment Focus: AstraZeneca Equity Research & Insights Damien Conover, CFA 12/05/15
AstraZeneca is Overvalued Equity Research & Insights Damien Conover, CFA 27/04/15
4 Pharma Stocks Best Placed in Cancer Market Equity Research & Insights Stefan Quenneville, CFA 30/03/15
Outperforming Manager Picks 3 Stocks to Get Rich Slowly Fund Research & Insights Emma Wall 17/02/15
Morningstar's View on Major Company Earnings and M&A Equity Research & Insights Holly Cook 06/02/15
Is Glaxo's Dividend at Risk? Equity Research & Insights Damien Conover, CFA 05/02/15
What Next for Pharmaceuticals? Equity Research & Insights Matthew Coffina, CFA 30/12/14
Woodford Blog: Will Pfizer Make Another Bid for Astra? Perspectives Woodford Funds 18/11/14
What's in the Pipeline for AstraZeneca Equity Research & Insights Damien Conover, CFA 07/11/14
British Pharmaceutical Companies Lag Global Peers Equity Research & Insights Damien Conover, CFA 04/11/14
Astra Shares Worth £35 Equity Research & Insights Damien Conover, CFA 04/06/14
Astra Overvalues Prospects Equity Research & Insights Damien Conover, CFA 07/05/14
Which Investment Trusts Hold Astra? Perspectives The Association of Investment Companies (AIC) 02/05/14
Analyst View: AstraZeneca Merger Equity Research & Insights Damien Conover, CFA 28/04/14
Page   1 of 2

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies